The global actinic keratosis treatment market is anticipated to grow at a significant CAGR of 5.0% during the forecast period 2022-2028. The major factor driving the growth of the market is the rising awareness regarding actinic keratosis skin disease. The hazardous outcomes of improper treatment of actinic keratosis, turning into skin cancer, are making people go for timely diagnosis and treatment. Moreover, the rise in government initiatives along with new product launches by major players in the market is propelling the growth of the market.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/actinic-keratosis-treatment-market
For instance, in December 2021, Biofrontera Inc., had enrolled in a Phase 1 study to evaluate the safety along with appropriateness of photodynamic therapy (PDT) in order to provide treatment for actinic keratosis (AK) using three tubes of Ameluz coupled with the company’s BF-RhodoLED XL lamp. Further, in July 2021, Athenex, Inc., announced that the Company had entered into licensing agreements and strategic partnerships with Seqirus Pty Ltd., a subsidiary of CSL Ltd., and AVIR Pharma Inc. for tirbanibulin. Apart from this, in December 2020, Athenex, Inc., announced that the US Food and Drug Administration (FDA) had approved Klisyri for the topical treatment of actinic keratosis (AK) on the face or scalp. Additionally, for launching the Klisyri, the company partnered with Almirall in the US.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Type
- By End-User
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape – including, 3M Co., Alma Lasers Inc., Almirall SA, Bausch Health Companies Inc., and Biofrontera AG, among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity??
Global Actinic Keratosis Treatment Market Report Segment
By Type
- Medication
o Fluorouracil
o Imiquimod
o Ingestol Mebutate
o Others
- Therapy
o Photodynamic Therapy
o Laser Surgery
o Others
By End-User
- Hospitals & Oncology Centers
- Dermatology Clinics
A full report of Actinic Keratosis Treatment Market is available at: https://www.omrglobal.com/industry-reports/actinic-keratosis-treatment-market
Actinic Keratosis Treatment Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- 3M Co.
- Alma Lasers, Inc.
- Almirall, S.A.
- Bausch Health Companies Inc.
- Biofrontera AG
- BioLineRx, Ltd.
- Cipher Pharmaceuticals, Inc.
- Galderma S.A.
- Hill Dermaceuticals, Inc.
- LEO Pharma A/S
- Mylan N.V.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
